NCT06166069

Brief Summary

Background: Ventral hernia repair poses challenges for surgeons due to controversies in approach, patient selection, and mesh selection. The GORE® SYNECOR Intraperitoneal (IP) Biomaterial, a hybrid mesh, aims to balance durability and infection risk. Objective: To analyze extended-term outcomes of using the Intaperitoneal device for ventral and incisional hernia repair. Methods: Retrospective analysis of patients undergoing surgery in eight Italian Surgery Centers, evaluating pIPOM and sIPOM techniques with GORE® SYNECOR IP Biomaterial. Preoperative evaluations included anthropometric measurements, comorbidities, CT scans, and GIQLI assessments. Surgical procedures and interventions were recorded. Postoperative complications, GIQLI changes, cosmesis, hernia recurrence, and mesh bulging were assessed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
272

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2022

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 18, 2023

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

December 1, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 12, 2023

Completed
Last Updated

December 18, 2023

Status Verified

December 1, 2023

Enrollment Period

1.8 years

First QC Date

December 1, 2023

Last Update Submit

December 12, 2023

Conditions

Keywords

Hernia

Outcome Measures

Primary Outcomes (7)

  • Number of patients affected by Superficial surgical site infections

    Superficial infections according to Clavien-Dindo criteria

    Within 30 days postoperatively

  • Number of patients affected by Deep surgical site infections

    Deep surgical site infections according to Clavien-Dindo criteria

    Within 30 days postoperatively

  • Number of patients affected by organ space infections

    Organ space infections according to Clavien-Dindo criteria

    Within 30 days postoperatively

  • Number of patients affected by Surgical Site Occurence

    Surgical Site Occurence Reported according to the Ventral Hernia Working Group (VHWG) definitions

    Within 30 days postoperatively

  • Postoperative pain

    Postoperative pain will be recorded according to the Visual Analogue Scale (VAS). The Visual Analogue Scale (VAS) measures pain intensity. The Visual Analogue Scale consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be').

    Postoperative pain will be recorded according to visual analogue scale Visual Analogue Scale at 1 month.

  • Postoperative pain

    Postoperative pain will be recorded according to the Visual Analogue Scale (VAS). The Visual Analogue Scale (VAS) measures pain intensity. The Visual Analogue Scale consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be').

    Postoperative pain will be recorded according to visual analogue scale Visual Analogue Scale at 6 month.

  • Postoperative pain

    Postoperative pain will be recorded according to the Visual Analogue Scale (VAS). The Visual Analogue Scale (VAS) measures pain intensity. The Visual Analogue Scale consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be').

    Postoperative pain will be recorded according to visual analogue scale Visual Analogue Scale at 12 month.

Secondary Outcomes (6)

  • Rate of Incisional Hernia at Clinical examination

    Patients are postoperatively examined at 1 months.

  • Rate of Incisional Hernia at Clinical examination

    Patients are postoperatively examined at 6 months.

  • Rate of Incisional Hernia at Clinical examination

    Patients are postoperatively examined at 12 months.

  • Rate of Incisional Hernia at ultrasonographic examination

    Patients are postoperatively examined at 1 months.

  • Rate of Incisional Hernia at ultrasonographic examination

    Patients are postoperatively examined at 6 months.

  • +1 more secondary outcomes

Study Arms (2)

A

Intraperitoneal Onlay Mesh(IPOM) Plus (GroupA) the laparoscopic closure of the hernia defect will be then performed with detached stitches, non-resorbable 1/0 suture with running intracorporeal suture or intra/extracorporeal interrupted suture

B

Intraperitoneal Onlay Mesh(IPOM) standard (Group B) no defect closure will be performed.

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Enrolled participants were allocated to either the pIPOM or sIPOM Groups based on the routine surgical practices of each center. In Group A, (IH) repairs were performed with the closure of the fascia using sutures (pIPOM). In Group B, laparoscopic IH repairs were carried out without closing the fascia (sIPOM). The choice of prosthesis dimensions was customized, with a minimum requirement of at least a 5 cm overlap. Postoperative complications, including morbidity (assessed according to the Clavien-Dindo classification \[9\]), mortality, length of hospital stay, and surgical reinterventions, were documented. All patients underwent regular follow-up at 1, 3, 6, and 12 months. During these follow-up visits, anthropometric measurements were conducted.

You may qualify if:

  • age \> 18 years
  • Clean wounds
  • Informed consent
  • Patients affected by Incisional and Ventral Hernia
  • Elective surgery
  • Hernia size between 3 e 10 cm

You may not qualify if:

  • age \< 18 years;
  • Life expectancy \< 24 months (as estimated by the operating surgeon), -
  • Pregnancy
  • Immunosuppressant therapy within 2 weeks before surgery
  • Clean-contaminated and contaminated, dirty wounds
  • Cirrhosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

francesco Pizza

Naples, 80131, Italy

Location

Related Publications (1)

  • Pizza F, Iuppa A, Maida P, Pilone V, Crucitti A, Carmen TPM, Morini L, Marin JN, Petitti T, Bertoglio C, Marte G, Sordelli I, Gili S, Lucido FS, Busciano L, D'Antonio D, Docimo L, Gambardella C. Postoperative outcomes and wound events in incisional hernia repair using hybrid mesh: results from a prospective multicenter italian study. Hernia. 2025 Feb 18;29(1):94. doi: 10.1007/s10029-025-03285-z.

MeSH Terms

Conditions

HerniaIncisional Hernia

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic Processes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, Md

Study Record Dates

First Submitted

December 1, 2023

First Posted

December 12, 2023

Study Start

January 1, 2021

Primary Completion

October 30, 2022

Study Completion

November 18, 2023

Last Updated

December 18, 2023

Record last verified: 2023-12

Locations